研究人员通过新的血液分析发现新的皮肤疾病,并找到有针对性的治疗方法。 Researchers identify new skin disease and find targeted treatment using novel blood analysis.

马里兰大学医学院的研究人员发现,在一名患有严重皮肤炎的红霉素病人中,出现了一种新的皮肤疾病。 Researchers at the University of Maryland School of Medicine have identified a new skin disease in a patient with erythroderma, a severe skin inflammation. 使用一种新的流动细胞测量技术 他们发现病人血液中 Interleukin-13 和 interleukin-17 的比例上升了 Using a novel flow cytometry technique, they found increased levels of interleukin-13 and interleukin-17 in the patient's blood. 利用这些细胞素的生物抑制剂进行有针对性的治疗,大大改善了患者的状况。 Targeted treatment with biologic inhibitors of these cytokines significantly improved the patient's condition. 这一突破可能带来新的诊断工具和精确疗法,治疗各种皮肤炎病。 This breakthrough could lead to new diagnostic tools and precision-based therapies for various inflammatory skin diseases.